A recently published study in which VAL was assessed in a small subgroup of 31 patients with prostate cancer and PSMA ligand PET/CT showed similar findings of PSMA-avid lymph nodes after vaccination (14). This evidence concerns the gene FOLH1 and prostate cancer.